Omega Therapeutics (OMGA) News Today $0.16 +0.01 (+3.83%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.16 +0.00 (+0.69%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & ImmunologyFebruary 19 at 12:41 PM | markets.businessinsider.comOmega Therapeutics secures $9.8M in DIP financingFebruary 14, 2025 | msn.comOmega Therapeutics announces board reshuffle and new directorJanuary 29, 2025 | msn.comOmega Therapeutics stock hits 52-week low at $0.52January 21, 2025 | msn.comOmega Therapeutics Appoints New Director Ravi MehrotraDecember 6, 2024 | tipranks.comOmega Therapeutics Reports Third Quarter 2024 ResultsNovember 19, 2024 | markets.businessinsider.comOmega Therapeutics price target lowered to $4 from $9 at Piper SandlerNovember 16, 2024 | markets.businessinsider.comPiper Sandler Remains a Buy on Omega Therapeutics (OMGA)November 16, 2024 | markets.businessinsider.comShares of Flagship-founded biotech fall as CEO departsNovember 15, 2024 | bizjournals.comOmega Therapeutics CEO Mahesh Karande to depart, Kaan Certel to succeedNovember 15, 2024 | markets.businessinsider.comOmega Therapeutics Restructures Leadership and Strategic FocusNovember 15, 2024 | markets.businessinsider.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Lowered by Raymond JamesRaymond James downgraded Omega Therapeutics from an "outperform" rating to a "market perform" rating in a research note on Friday.November 15, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Price Target Cut to $4.00 by Analysts at Piper SandlerPiper Sandler lowered their target price on Omega Therapeutics from $9.00 to $4.00 and set an "overweight" rating for the company in a research note on Friday.November 15, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9% - Should You Sell?Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9% - Here's What HappenedNovember 8, 2024 | marketbeat.comOmega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific MeetingsOctober 15, 2024 | globenewswire.comOmega Therapeutics Appoints New DirectorOctober 6, 2024 | investing.comOmega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature CommunicationsSeptember 17, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Shares Up 0.8%Omega Therapeutics (NASDAQ:OMGA) Shares Up 0.8%September 10, 2024 | marketbeat.comOmega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of ResearchAugust 14, 2024 | globenewswire.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) Decreased by AnalystOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Analysts at Wedbush decreased their Q3 2024 earnings estimates for shares of Omega Therapeutics in a report issued on Tuesday, August 6th. Wedbush analyst R. Driscoll now expects that the company will earn ($0.34) per share for the quarter, dAugust 9, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Quotes, Forecast and News SummaryAugust 8, 2024 | benzinga.comOmega Therapeutics (NASDAQ:OMGA) Releases Earnings Results, Beats Expectations By $0.06 EPSOmega Therapeutics (NASDAQ:OMGA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.30) earnings per share for the quarter, topping analysts' consensus estimates of ($0.36) by $0.06. Omega Therapeutics had a negative net margin of 1,868.35% and a negative return on equity of 136.04%. The firm had revenue of $2.13 million for the quarter, compared to the consensus estimate of $1.25 million.August 7, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Reaffirmed by WedbushWedbush reiterated an "outperform" rating and set a $12.00 price objective on shares of Omega Therapeutics in a research note on Wednesday.August 7, 2024 | marketbeat.comOmega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressAugust 6, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Trading Up 4.3%Omega Therapeutics (NASDAQ:OMGA) Shares Up 4.3%July 24, 2024 | marketbeat.comOmega Therapeutics Announces Election of Richard N. Kender to Board of DirectorsJune 24, 2024 | globenewswire.comRaymond James Begins Coverage on Omega Therapeutics (NASDAQ:OMGA)Raymond James started coverage on Omega Therapeutics in a research report on Tuesday. They set an "outperform" rating and a $12.00 target price for the company.June 18, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Trading 14.5% Higher Omega Therapeutics (NASDAQ:OMGA) Trading 14.5% HigherJune 6, 2024 | marketbeat.comOmega Therapeutics To Participate In Two Upcoming Investor ConferencesMay 30, 2024 | globenewswire.comOmega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business OfficerMay 29, 2024 | globenewswire.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. Raised by HC Wainwright (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for Omega Therapeutics in a report released on Monday, May 13th. HC Wainwright analyst R. Burns now forecasts that the company will post earninMay 15, 2024 | marketbeat.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Expected to Post Q3 2025 Earnings of ($0.29) Per ShareOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Investment analysts at HC Wainwright issued their Q3 2025 earnings per share (EPS) estimates for Omega Therapeutics in a research note issued on Monday, May 13th. HC Wainwright analyst R. Burns forecasts that the company will post earnings peMay 14, 2024 | marketbeat.comBuy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial PerformanceMay 13, 2024 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Omega Therapeutics (NASDAQ:OMGA)HC Wainwright reissued a "buy" rating and set a $12.00 price target on shares of Omega Therapeutics in a report on Monday.May 13, 2024 | marketbeat.comEquities Analysts Offer Predictions for Omega Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities research analysts at Chardan Capital issued their FY2025 earnings per share estimates for shares of Omega Therapeutics in a research note issued on Tuesday, May 7th. Chardan Capital analyst K. Nakae anticipates that the company willMay 10, 2024 | marketbeat.comOmega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersMay 8, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Receives "Buy" Rating from Chardan CapitalChardan Capital reiterated a "buy" rating and issued a $7.00 target price on shares of Omega Therapeutics in a research report on Tuesday.May 7, 2024 | marketbeat.com4 Analysts Have This To Say About Omega TherapeuticsMay 7, 2024 | markets.businessinsider.comOmega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In LineMay 7, 2024 | finance.yahoo.comBuy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical TrialsMay 7, 2024 | markets.businessinsider.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | markets.businessinsider.comOmega Therapeutics (NASDAQ:OMGA) Rating Reiterated by WedbushWedbush reiterated an "outperform" rating and issued a $12.00 price objective on shares of Omega Therapeutics in a research report on Monday.May 6, 2024 | marketbeat.comOMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024May 6, 2024 | investorplace.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | globenewswire.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Forecasted to Post Q1 2024 Earnings of ($0.38) Per ShareOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Analysts at HC Wainwright increased their Q1 2024 EPS estimates for Omega Therapeutics in a research report issued to clients and investors on Tuesday, April 30th. HC Wainwright analyst R. Burns now forecasts that the company will post earninMay 2, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Omega Therapeutics (NASDAQ:OMGA)HC Wainwright reissued a "buy" rating and issued a $12.00 target price on shares of Omega Therapeutics in a research report on Tuesday.April 30, 2024 | marketbeat.comOmega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingApril 23, 2024 | globenewswire.comOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlApril 9, 2024 | globenewswire.comOmega Therapeutics, Inc. to Post FY2024 Earnings of ($1.31) Per Share, Chardan Capital Forecasts (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Research analysts at Chardan Capital upped their FY2024 EPS estimates for shares of Omega Therapeutics in a research note issued to investors on Monday, April 1st. Chardan Capital analyst K. Nakae now anticipates that the company will earn ($April 4, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Earns "Overweight" Rating from Piper SandlerPiper Sandler reissued an "overweight" rating and issued a $9.00 price objective (down from $10.00) on shares of Omega Therapeutics in a report on Wednesday.April 3, 2024 | marketbeat.com Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter. Email Address OMGA Media Mentions By Week OMGA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMGA News Sentiment▼0.020.60▲Average Medical News Sentiment OMGA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMGA Articles This Week▼11▲OMGA Articles Average Week Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Xilio Therapeutics News Today Dyadic International News Today AlloVir News Today Atara Biotherapeutics News Today OS Therapies News Today Ovid Therapeutics News Today Generation Bio News Today Eliem Therapeutics News Today ImmuCell News Today FibroBiologics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMGA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
